Adam Ang
Alongside generative AI, the large database has been foundational to the development of its latest AI-powered drug discovery system.
Also, AIRS Medical has recently signed a strategic partnership to accelerate its expansion in Australia and New Zealand.
Also, Qure.ai has obtained breakthrough device designation for its tuberculosis AI.
CitiusTech claims that most genAI proof of concepts is delayed due to the lack of trust.
Based on latest survey in South Korea, there is a difference in the use of mobile health apps and devices between frail and healthy seniors.
Also, SELVAS Healthcare will be bringing to South Korea a foreign contender to the booming AI-based medical imaging market.
Also, researchers from Singapore and Kazakhstan have used AI and heat imaging for the early detection of breast cancer.
Also, Seegene will be leveraging Microsoft's AI to advance the development of syndromic quantitative PCR diagnostic tests globally.
This comes three months after getting regulatory approval from Singapore’s Health Sciences Authority for its latest digital twin solution.
Despite the hype, this buzzing AI will still have to prove its worth for Asia's cautious hospitals, says one health tech vendor.